SCHEMBL22700720

SCHEMBL22700720

CC1=C(C2=C(C)C(=O)c3c(c(/C=N/Nc4ccccc4)c(O)c(O)c3C(C)C)C2=O)C(=O)c2cc(O)c(O)c(C(C)C)c2C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 16/20 0.42
GAA P10253 15/20 0.42
ALDH1A1 P00352 14/20 0.42
SMN1; SMN2 Q16637 10/20 0.42
MEN1 O00255 7/20 0.42
KMT2A Q03164 7/20 0.42
ALOX12 P18054 5/20 0.42
TDP1 Q9NUW8 7/20 0.36
GFER P55789 3/20 0.36
KDM4E B2RXH2 10/20 0.36
LMNA P02545 4/20 0.35
HPGD P15428 5/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
HTT P42858 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP3A4 P08684 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22700400 0.86 MAPT (0.36) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL22700775 0.83 MAOA (0.36) MAPTGAAALDH1A1SMN1; SMN2MEN1
SCHEMBL22700390 0.80 MCL1 (0.50) MAPTGAAALDH1A1SMN1; SMN2MEN1
SCHEMBL22686504 0.80 ALB (0.42) MAPTGAAALDH1A1SMN1; SMN2MEN1
SCHEMBL22700375 0.80 KDM4E (0.41) MAPTGAAALDH1A1SMN1; SMN2MEN1
SCHEMBL22700765 0.79 SMN1; SMN2 (0.32) ALDH1A1SMN1; SMN2KMT2AL3MBTL1
SCHEMBL22700704 0.79 MCL1 (0.46) MAPTGAAALDH1A1SMN1; SMN2MEN1
SCHEMBL22700398 0.78 MEN1 (0.35) MAPTGAAALDH1A1MEN1KMT2A
SCHEMBL22700489 0.77 BCL2 (0.40) MEN1KMT2ABCL2MCL1
SCHEMBL22700774 0.77 CNR2 (0.34) MAPTGAAALDH1A1SMN1; SMN2ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200369618-A1 ASYMMETRIC DERIVATIVES OF POLYPHENOLS OF THE DINAPHTHALINE SERIES, PROCESS OF PREPARING AND USE THEREOF Nearmedic International Limited (CY) 2020-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200369618-A1 ASYMMETRIC DERIVATIVES OF POLYPHENOLS OF THE DINAPHTHALINE SERIES, PROCESS OF PREPARING AND USE THEREOF DNM2, DNM1, MAVS MAPT 3116/4885GAA 160/4885ALDH1A1 859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.